Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Pitavastatin (Primary)
- Indications Asthenia
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PREPARE
- 21 Feb 2018 Planned End Date changed from 28 Feb 2023 to 28 Feb 2022.
- 21 Feb 2018 Planned primary completion date changed from 28 Feb 2023 to 28 Feb 2022.
- 21 Feb 2018 Status changed from recruiting to active, no longer recruiting.